iOmx Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- iOmx Therapeutics's estimated annual revenue is currently $14.1M per year.
- iOmx Therapeutics's estimated revenue per employee is $201,000
Employee Data
- iOmx Therapeutics has 70 Employees.
- iOmx Therapeutics grew their employee count by 23% last year.
iOmx Therapeutics's People
| Name | Title | Email/Phone |
|---|
iOmx Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is iOmx Therapeutics?
iOmx is a new-age start-up biotech company in the immuno-oncology field. We are focused on innovation-driven research to advance our proprietary early stage novel immune-checkpoint molecules through pre-clinical and clinical development. Follow this page to keep yourself updated about our journey as we advance in creating next-generation immunotherapy treatments for cancer patients. Imprint: https://iomx.com/imprint
keywords:N/A
N/A
Total Funding
70
Number of Employees
$14.1M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
iOmx Therapeutics News
While targeted therapeutics have recently emerged as alternatives to harsh ... and iOmx, and works closely with academic founder Dr. Jeker.
MARTINSRIED / MUNICH, Germany, April 07, 2022 (GLOBE NEWSWIRE) -- iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer...